Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same author

Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004.

Gynecologic oncology·2026
Same author

ChatGPT Versus Custom-Trained Chatbot for Urogynecology Surgery Counseling.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Timing of Midurethral Sling Placement During Minimally Invasive Sacrocolpopexy.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Rethinking depression diagnosis in ovarian cancer: The role of somatic symptoms.

Cancer·2026
Same author

Identifying ovarian cancer with AI analysis of abdominal CT scans.

Gynecologic oncology·2026

Related Experiment Video

Updated: Sep 17, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.7K

Identifying ovarian cancer with machine learning DNA methylation pattern analysis.

Jesus Gonzalez Bosquet1,2, Vincent M Wagner3,4, Douglas Russo5

  • 1Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Dr., Iowa City, IA, 52242, USA. jesus-gonzalezbosquet@uiowa.edu.

Scientific Reports
|July 2, 2025
PubMed
Summary

Early detection of epithelial ovarian cancer (EOC) is crucial. Artificial intelligence and DNA methylation analysis accurately predict high-grade serous ovarian cancer (HGSC) using only 9 key markers.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K

Related Experiment Videos

Last Updated: Sep 17, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.4K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Epithelial ovarian cancer (EOC) is frequently diagnosed at advanced stages, hindering effective treatment and impacting patient survival.
  • Improved early diagnostic methods for EOC are essential to enhance overall survival rates.

Purpose of the Study:

  • To develop and optimize an artificial intelligence (AI) model for the early prediction of high-grade serous ovarian cancer (HGSC).
  • To identify a minimal set of informative DNA methylation markers for accurate HGSC detection.

Main Methods:

  • A case-control study was conducted using DNA methylation data from surgical specimens.
  • Initial prediction models were built using the MethylNet AI methodology.
  • Model optimization involved univariate ANOVA and multivariate lasso regression to select informative methylation probes.
  • Validation was performed using diverse analytical approaches and an independent DNA methylation experiment.

Main Results:

  • Initial AI models achieved 100% accuracy (AUC=100%) in predicting HGSC.
  • A step-wise optimization process identified 9 key methylated probes with 100% predictive accuracy (AUC=100%).
  • Validated models demonstrated excellent performance in independent testing.

Conclusions:

  • A highly accurate AI-driven model utilizing 9 DNA methylation markers can predict HGSC.
  • This approach offers a promising strategy for the early diagnosis of epithelial ovarian cancer.
  • Optimized AI models provide a simplified yet powerful tool for HGSC detection, potentially improving patient outcomes.